However, using the serum HFABP level to detect patients with AKI would have several limitations in comparison with other reno-tubular biomarkers such as serum NGAL level or NAG level, as the elevation of these reno-tubular biomarkers in serum clearly indicates renal damage and has superior diagnostic and prognostic significance [6–11]. This evidence concerns the gene LCN2 and acute kidney injury.